E 78 Pill - white round, 5mm
Pill with imprint E 78 is White, Round and has been identified as Zolpidem Tartrate 5 mg. It is supplied by Aurobindo Pharma.
Zolpidem is used in the treatment of Insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for E 78
Zolpidem Tartrate
- Imprint
- E 78
- Strength
- 5 mg
- Color
- White
- Size
- 5.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Aurobindo Pharma
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
magnesium stearate,
hypromellose 2910 (5 mPa.s),
polyethylene glycol 400,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 65862-0159 | Aurobindo Pharma Limited |
| 16714-0621 | NorthStar Rx LLC |
Related images for "E 78"
More about zolpidem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,054)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- Breastfeeding
- En español
Patient resources
- Zolpidem drug information
- Zolpidem (Oral) (Advanced Reading)
- Zolpidem (Oromucosal, Sublingual) (Advanced Reading)
- Zolpidem Extended-Release Tablets
- Zolpidem Oral Spray
Other brands
Ambien, Ambien CR, Zolpimist, Intermezzo, Edluar
Professional resources
- Zolpidem monograph
- Zolpidem (FDA)
- Zolpidem Capsule (FDA)
- Zolpidem Extended Release (FDA)
- Zolpidem Sublingual (FDA)
Other brands
Ambien, Ambien CR, Zolpimist, Intermezzo, Edluar
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
